Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.

Author: Del FabbroMassimo, GallesioGiorgia, MozzatiMarco

Paper Details 
Original Abstract of the Article :
Bisphosphonate related osteonecrosis of the jaw (BRONJ) is an adverse drug reaction consisting of progressive bone destruction in the maxillofacial region of patients under current or previous treatment with a bisphosphonate. Autologous platelet concentrates (APC) demonstrated to enhance bone and so...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.ejca.2014.10.015

データ提供:米国国立医学図書館(NLM)

Autologous Platelet Concentrates for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious adverse drug reaction that can occur in patients taking bisphosphonates. This systematic review explores the potential of autologous platelet concentrates (APC) for treating and preventing BRONJ. APC is a concentrated solution of platelets derived from the patient's own blood. The researchers reviewed the available literature to assess the evidence for using APC in BRONJ. The study found that while APC has shown promise in enhancing bone and soft tissue healing in oral surgery procedures, there is limited evidence to support its use in BRONJ. Further research is needed to determine the efficacy of APC in managing this condition.

Autologous Platelet Concentrates: A Potential Treatment for BRONJ?

This systematic review highlights the potential of APC as a treatment option for BRONJ. However, the study acknowledges the need for further research to confirm its efficacy and safety in managing this condition. It is important to consult with a healthcare professional to discuss all treatment options and make informed decisions regarding BRONJ management.

Managing BRONJ: Seeking Expert Care and Exploring Treatment Options

BRONJ is a serious condition that requires expert medical attention. This systematic review emphasizes the importance of consulting with a healthcare professional to discuss the best treatment options for your individual needs. It is essential to seek care from a specialist experienced in managing BRONJ and to stay informed about the latest research and treatment advancements.

Dr. Camel's Conclusion

This systematic review explores the potential of autologous platelet concentrates (APC) for treating and preventing bisphosphonate-related osteonecrosis of the jaw (BRONJ). Just as a camel adapts to the desert's harsh conditions, researchers are continually seeking new and innovative ways to manage complex medical conditions. While APC shows promise, further research is needed to confirm its efficacy in managing BRONJ.

Date :
  1. Date Completed 2015-04-17
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

25466505

DOI: Digital Object Identifier

10.1016/j.ejca.2014.10.015

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.